๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Survival comparison of radiosurgery eligible and ineligible malignant glioma patients treated with hyperfractionated radiation therapy (RT) and BCNU: a report of radiation therapy oncology group (RTOG) 83-02

โœ Scribed by W.J. Curran Jr; C.B. Scott; J.S Nelson; L.A. Martin; A.S. Weinstein; T.L. Phillipss; K. Murray; A.J. Fischbach; D. Yakar; J.G. Schwade; B.W. Cornl; D.F. Nelsonlo

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
102 KB
Volume
24
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Final report of a phase I/II trial of hy
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02
โœ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho